➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Mallinckrodt
Merck
Medtronic
Express Scripts

Last Updated: October 17, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211581


Email this page to a colleague

« Back to Dashboard

NDA 211581 describes TRIAMTERENE, which is a drug marketed by Agnitio, Ani Pharms, Cadila, Chartwell Rx, Duramed Pharms Barr, Lannett Co Inc, Mylan, Novartis, Sandoz, Vitarine, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, Watson Labs, and Zydus Pharms, and is included in twenty-two NDAs. It is available from one supplier. Additional details are available on the TRIAMTERENE profile page.

The generic ingredient in TRIAMTERENE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 211581
Tradename:TRIAMTERENE
Applicant:Agnitio
Ingredient:triamterene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 211581
Medical Subject Heading (MeSH) Categories for 211581
Suppliers and Packaging for NDA: 211581
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMTERENE triamterene CAPSULE;ORAL 211581 ANDA TRUPHARMA LLC 52817-364 52817-364-10 100 CAPSULE in 1 BOTTLE (52817-364-10)
TRIAMTERENE triamterene CAPSULE;ORAL 211581 ANDA TRUPHARMA LLC 52817-365 52817-365-10 100 CAPSULE in 1 BOTTLE (52817-365-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Aug 19, 2019TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Aug 19, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Moodys
McKinsey
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.